Department of Medicine-Gastroenterology & Hepatology, University of Arizona, Tucson, Arizona.
Department of Cellular & Molecular Medicine, University of Arizona, Tucson, Arizona.
Gastroenterology. 2022 Aug;163(2):411-425.e4. doi: 10.1053/j.gastro.2022.04.031. Epub 2022 Apr 26.
BACKGROUND & AIMS: A subset of myeloid-derived suppressor cells (MDSCs) that express murine Schlafen4 (SLFN4) or its human ortholog SLFN12L polarize in the Helicobacter-inflamed stomach coincident with intestinal or spasmolytic polypeptide-expressing metaplasia. We propose that individuals with a more robust response to damage-activated molecular patterns and increased Toll-like receptor 9 (TLR9) expression are predisposed to the neoplastic complications of Helicobacter infection.
A mouse or human Transwell co-culture system composed of dendritic cells (DCs), 2-dimensional gastric epithelial monolayers, and Helicobacter were used to dissect the cellular source of interferon-α (IFNα) in the stomach by flow cytometry. Conditioned media from the co-cultures polarized primary myeloid cells. MDSC activity was determined by T-cell suppression assays. In human subjects with intestinal metaplasia or gastric cancer, the rs5743836 TLR9T>C variant was genotyped and linked to TLR9, IFNα, and SLFN12L expression by immunohistochemistry. Nuclear factor-κB binding to the TLR9 C allele was determined by electrophoretic mobility shift assays.
Helicobacter infection induced gastric epithelial and plasmacytoid DC expression of TLR9 and IFNα. Co-culturing primary mouse or human cells with DCs and Helicobacter induced TLR9, IFNα secretion, and SLFN-MDSC polarization. Neutralizing IFNα in vivo mitigated Helicobacter-induced spasmolytic polypeptide-expressing metaplasia. The TLR9 minor C allele creates a nuclear factor-κB binding site associated with higher levels of TLR9, IFNα, and SLFN12L in Helicobacter-infected stomachs that correlated with a greater incidence of metaplasias and cancer.
TLR9 plays an essential role in the production of IFNα and polarization of SLFN MDSCs on Helicobacter infection. Subjects carrying the rs5743836 TLR9 minor C allele are predisposed to neoplastic complications if chronically infected.
在幽门螺杆菌感染的胃中,表达鼠 Schlafen4(SLFN4)或其人类同源物 SLFN12L 的髓系来源抑制细胞(MDSCs)亚群发生极化,同时伴有肠化生或平滑肌多肽表达。我们提出,对损伤激活的分子模式和 Toll 样受体 9(TLR9)表达增加有更强反应的个体更容易发生幽门螺杆菌感染的肿瘤并发症。
使用由树突状细胞(DC)、二维胃上皮单层和幽门螺杆菌组成的小鼠或人 Transwell 共培养系统,通过流式细胞术分析胃中干扰素-α(IFNα)的细胞来源。共培养物的条件培养基极化原代髓系细胞。通过 T 细胞抑制试验测定 MDSC 活性。在患有肠化生或胃癌的人类受试者中,对 TLR9T>C 变体进行基因分型,并通过免疫组织化学法将其与 TLR9、IFNα 和 SLFN12L 表达联系起来。通过电泳迁移率变动分析测定核因子-κB 与 TLR9 C 等位基因的结合。
幽门螺杆菌感染诱导胃上皮细胞和浆细胞样 DC 表达 TLR9 和 IFNα。与 DC 和幽门螺杆菌共培养原代小鼠或人类细胞诱导 TLR9、IFNα 分泌和 SLFN-MDSC 极化。体内中和 IFNα 可减轻幽门螺杆菌诱导的平滑肌多肽表达的化生。TLR9 次要 C 等位基因创建了一个核因子-κB 结合位点,与幽门螺杆菌感染胃中 TLR9、IFNα 和 SLFN12L 的水平升高相关,这与化生和癌症的发生率更高相关。
TLR9 在幽门螺杆菌感染时 IFNα 的产生和 SLFN MDSC 的极化中起重要作用。如果慢性感染,携带 rs5743836 TLR9 次要 C 等位基因的个体易发生肿瘤并发症。